Raquel Laza‐Briviesca

1.5k total citations
19 papers, 384 citations indexed

About

Raquel Laza‐Briviesca is a scholar working on Immunology, Cancer Research and Molecular Biology. According to data from OpenAlex, Raquel Laza‐Briviesca has authored 19 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 5 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in Raquel Laza‐Briviesca's work include Immune Cell Function and Interaction (9 papers), T-cell and B-cell Immunology (7 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Raquel Laza‐Briviesca is often cited by papers focused on Immune Cell Function and Interaction (9 papers), T-cell and B-cell Immunology (7 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Raquel Laza‐Briviesca collaborates with scholars based in Spain, United Kingdom and Netherlands. Raquel Laza‐Briviesca's co-authors include Alberto Cruz‐Bermúdez, Mariano Provencio, Atocha Romero, Virginia Calvo, Paloma Martín, Aránzazu García‐Grande, Ramiro J. Vicente-Blanco, Sara Laine-Menéndez, Fernando Franco and Clara Salas and has published in prestigious journals such as Nature Communications, PLoS ONE and Scientific Reports.

In The Last Decade

Raquel Laza‐Briviesca

18 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raquel Laza‐Briviesca Spain 9 206 167 118 86 72 19 384
Kehao Le China 9 216 1.0× 170 1.0× 103 0.9× 103 1.2× 72 1.0× 13 387
Zhenqian Wu China 11 169 0.8× 98 0.6× 178 1.5× 72 0.8× 118 1.6× 16 368
Jiafei Lin China 12 271 1.3× 173 1.0× 80 0.7× 113 1.3× 124 1.7× 15 491
Weiying Li China 11 143 0.7× 106 0.6× 126 1.1× 37 0.4× 97 1.3× 29 363
Yifei Mu China 14 228 1.1× 133 0.8× 140 1.2× 94 1.1× 46 0.6× 27 457
Weilong Chen China 9 246 1.2× 118 0.7× 197 1.7× 127 1.5× 53 0.7× 14 436
Yao-Chen Wang Taiwan 11 345 1.7× 136 0.8× 152 1.3× 67 0.8× 75 1.0× 13 489
Yann Duchartre United States 5 369 1.8× 107 0.6× 94 0.8× 40 0.5× 48 0.7× 7 467
Lalita Yadav India 5 213 1.0× 153 0.9× 134 1.1× 30 0.3× 35 0.5× 13 407
Liping Fan China 10 243 1.2× 127 0.8× 89 0.8× 75 0.9× 27 0.4× 34 407

Countries citing papers authored by Raquel Laza‐Briviesca

Since Specialization
Citations

This map shows the geographic impact of Raquel Laza‐Briviesca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raquel Laza‐Briviesca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raquel Laza‐Briviesca more than expected).

Fields of papers citing papers by Raquel Laza‐Briviesca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raquel Laza‐Briviesca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raquel Laza‐Briviesca. The network helps show where Raquel Laza‐Briviesca may publish in the future.

Co-authorship network of co-authors of Raquel Laza‐Briviesca

This figure shows the co-authorship network connecting the top 25 collaborators of Raquel Laza‐Briviesca. A scholar is included among the top collaborators of Raquel Laza‐Briviesca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raquel Laza‐Briviesca. Raquel Laza‐Briviesca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kim, Taehyeung, Marta Martínez‐Bonet, Qiang Wang, et al.. (2024). Non-coding autoimmune risk variant defines role for ICOS in T peripheral helper cell development. Nature Communications. 15(1). 2150–2150. 8 indexed citations
2.
Laza‐Briviesca, Raquel, Taehyeung Kim, Louis‐Marie Charbonnier, et al.. (2024). The ‘Treg paradox’ in inflammatory arthritis. Nature Reviews Rheumatology. 21(1). 9–21. 5 indexed citations
3.
Serna‐Blasco, Roberto, Estela Sánchez‐Herrero, Marta Casarrubios, et al.. (2021). KRAS p.G12C mutation occurs in 1% of EGFR-mutated advanced non-small-cell lung cancer patients progressing on a first-line treatment with a tyrosine kinase inhibitor. ESMO Open. 6(5). 100279–100279. 5 indexed citations
4.
Cruz‐Bermúdez, Alberto, et al.. (2021). The Role of Metabolism in Tumor Immune Evasion: Novel Approaches to Improve Immunotherapy. Biomedicines. 9(4). 361–361. 11 indexed citations
5.
Laza‐Briviesca, Raquel, et al.. (2020). Lung Cancer and COVID-19: Therapeutic Implications. 2(1). 1 indexed citations
6.
Romero, Atocha, Roberto Serna‐Blasco, Estela Sánchez‐Herrero, et al.. (2020). ctDNA analysis reveals different molecular patterns upon disease progression in patients treated with osimertinib. Translational Lung Cancer Research. 9(3). 532–540. 17 indexed citations
7.
Laza‐Briviesca, Raquel, Alberto Cruz‐Bermúdez, Marta Casarrubios, et al.. (2019). Immune cell biomarkers on neo-adjuvant chemo-immunotherapy treatment for resectable stage IIIA NSCLC patients. Annals of Oncology. 30. v507–v507. 3 indexed citations
8.
Cruz‐Bermúdez, Alberto, Raquel Laza‐Briviesca, Ramiro J. Vicente-Blanco, et al.. (2019). Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition. Free Radical Biology and Medicine. 135. 167–181. 135 indexed citations
9.
Provencio, Mariano, Clara Pérez-Barrios, Virginia Calvo, et al.. (2019). Next-generation sequencing for tumor mutation quantification using liquid biopsies. Clinical Chemistry and Laboratory Medicine (CCLM). 58(2). 306–313. 9 indexed citations
10.
Pérez-Barrios, Clara, Matti Romo, Elodie Sanchez, et al.. (2019). Utility of high sensitivity NGS for EGFR exon 19 mutations detection from circulating-free DNA. Clinica Chimica Acta. 493. S157–S158.
11.
Cox, S.T., Robert Danby, Diana Hernandez, et al.. (2018). Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma. Frontiers in Immunology. 9. 1282–1282. 13 indexed citations
12.
Cruz‐Bermúdez, Alberto, Raquel Laza‐Briviesca, Ramiro J. Vicente-Blanco, et al.. (2018). Cancer-associated fibroblasts modify lung cancer metabolism involving ROS and TGF-β signaling. Free Radical Biology and Medicine. 130. 163–173. 109 indexed citations
13.
Cruz‐Bermúdez, Alberto, Ramiro J. Vicente-Blanco, Raquel Laza‐Briviesca, et al.. (2017). PGC-1alpha levels correlate with survival in patients with stage III NSCLC and may define a new biomarker to metabolism-targeted therapy. Scientific Reports. 7(1). 24 indexed citations
14.
Cox, S.T., Raquel Laza‐Briviesca, Bernat Soria, et al.. (2015). Umbilical cord blood plasma contains soluble NKG2D ligands that mediate loss of natural killer cell function and cytotoxicity. European Journal of Immunology. 45(8). 2324–2334. 18 indexed citations
15.
Laza‐Briviesca, Raquel, Linda Ariza‐McNaughton, Martha Luevano, et al.. (2015). Natural Killer Cells Improve Hematopoietic Stem Cell Engraftment by Increasing Stem Cell Clonogenicity In Vitro and in a Humanized Mouse Model. PLoS ONE. 10(10). e0138623–e0138623. 9 indexed citations
16.
Laza‐Briviesca, Raquel, et al.. (2015). Further diversity of the 5′ promoter region of the MHC class I‐related chain B gene. International Journal of Immunogenetics. 43(1). 45–48. 3 indexed citations
17.
Cox, S.T., et al.. (2015). Characterization of 5′ promoter and exon 1–3 polymorphism of the RAET1E gene. Human Immunology. 77(1). 96–103. 8 indexed citations
18.
Laza‐Briviesca, Raquel, Aurore Saudemont, J. Alejandro Madrigal, & S.T. Cox. (2015). Two novel 5′ promoter sequences of the MHC class I‐related chain A gene. International Journal of Immunogenetics. 42(3). 226–227. 1 indexed citations
19.
Cox, S.T., Raquel Laza‐Briviesca, J. Alejandro Madrigal, & Aurore Saudemont. (2014). Further polymorphism of the RAET1E/ULBP4 gene in humans. Tissue Antigens. 84(4). 435–437. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kehao Le Breakdown of academic impact, for papers by Zhenqian Wu Breakdown of academic impact, for papers by Jiafei Lin Breakdown of academic impact, for papers by Weiying Li Breakdown of academic impact, for papers by Yifei Mu Breakdown of academic impact, for papers by Weilong Chen Breakdown of academic impact, for papers by Yao-Chen Wang Breakdown of academic impact, for papers by Yann Duchartre Breakdown of academic impact, for papers by Lalita Yadav Breakdown of academic impact, for papers by Liping Fan
Rankless by CCL
2026